☆ 4.6 Letter

Efficacy of ruxolitinib cream in vitiligo by patient characteristics and affected body areas: Descriptive subgroup analyses from a phase 2, randomized, double-blind trial

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 86, Issue 6, Pages 1398-1401

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2021.05.047

Keywords

-

Categories

Dermatology

Funding

  1. Incyte Corporation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.